How is Japanese biotech R&D structured, who are the key stakeholders, and how can European SMEs profit and find Japanese partners?
DJWパートナー日欧産業協力センター主催イベント
Japan spends consistently over 3% of its GDP on R&D, of which some 70% come from industry. Concerning biotech-related R&D, more than half is directed towards pharmaceutical and medical goals, but agricultural, industrial and environmental biotech are recently getting more attention in view of a future “bioeconomy” based on “smart cells” and a better integration of biological and digital innovations. Japanese industry, supported by long-term government programs, is eager to identify such innovations world-wide, and mechanisms which are in place to establish international partnerships will be discussed.
Further information is available here.
Target group
The webinar targets start-ups with innovative biotech-related products or services that look for funding from Japanese medical, agricultural, chemical or environmental industries.
Registration
Deadline: 20 September 2021
Please keep in mind that this webinar is only accessible to EU companies which are registered to the EU Business in Japan website.
© Pixabay
